We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


StemCells Regains Compliance for Continued NASDAQ Global Market Listing

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "StemCells Regains Compliance for Continued NASDAQ Global Market Listing"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

StemCells, Inc., has announced that it has received notification from The NASDAQ Stock Market that the Company has regained compliance with the minimum bid price requirement.

In order to continue listing on the NASDAQ Global Market, the NASDAQ Listing Rules require the Company’s stock to evidence a closing of bid price of $1.00 per share or more for ten consecutive days.

On July 20, 2011, the closing bid price of the Company’s common stock was $3.75 per share, the tenth consecutive day the bid price closed above $1.00 per share.